Clinical Tech Leader, eClinical Platforms, Clinical Trial Patient Tech, Wearables, Compliance, DCT, RWD, RWE

AI, Holographic AI chip interface with European Union flag-GettyImages-2244741422

How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)

Learn how to comply with the EU AI Act when AI is used in GCP-critical eTMF contexts in part two of this series by Donatella Ballerini.

More Featured Editorial

ON-DEMAND WEBINARS

iStock-1130696738-solution-child-patient-doctor-success

Key Considerations For A Direct-to-Patient Clinical Trial

This webinar explores important considerations for developing a Direct-to-Patient strategy and the RTSM features needed to support its execution.

webinar__econsent_a_flexible_approach__final

The Revival Of Electronic Informed Consent

The clinical research industry has been reluctant to adopt eConsent for several reasons. Unearth how the industry should continue exploring and implementing digital technologies in earnest in the future.

The New Vaccine Race: Why A Decentralized Approach Wins

What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.

Accelerate Parkinson's Drug Development With Active, Passive DHT Monitoring

Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Clinical Data Needs Smart Automation Now for a Better AI Future
AI holds the potential to enhance clinical trial efficiency, but it relies on a foundation of clean data and intelligent automation to be effective.
How Long Is Your RTSM Risk Mitigation List?
While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
The Transformative Impact Of EDC Systems In 2025
The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.
Trends Shaping The Pharmaceutical Industry's Future
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
Using Virtual Study Coordinators For EDC Entry And Query Resolution To Speed Up Data Access And Cleaning
The piece showcases how the effective use of CRIO can significantly enhance site performance, supporting recruitment and diversity objectives for sponsors.
Strengthening eClinical Data Integrity: Data Monitoring
As the use of eCOA expands to incorporate more submission-critical elements, especially key endpoints and factors contributing to protocol analyses, learn how customized compliance strategies are more important than ever to ensure data integrity.
The Role Of AI Throughout The Clinical Research Journey
AI revolutionizes clinical trials by optimizing study design, automating processes, enhancing patient-centric approaches, and providing real-time insights.
Finding The Optimal IRT/RTSM Design For Your Clinical Trial
Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
When Protocol Amendments Meet RTSM: From Headache To High-Performance
Learn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
Streamlined Site Study Start-Up
Explore the critical process of Study Start-Up (SSU) in clinical trials, with an emphasis on the collaborative efforts of sponsors and research sites to enhance efficiency and reduce timelines.